Your RWD starts in the pharmacy
Discover the insights from the sector that Pascal shared during his recent appearance at the RWD Pharmacademy.
Earlier this month, Pascal shared how Real World Data (RWD) is transforming pharmacy at the RWD PharmAcademy by Pharma.be. Here are a few key insights.
RWD is more relevant than ever
The EMA recently released its 4th progress report on real-world evidence, showing that 30% of studies directly supported a regulatory decision.
This means a clear shift: robust RWD is no longer optional, it’s what regulators expect. Having early access to high-quality data creates a real advantage, whether you’re building a reimbursement dossier, preparing a Managed Entry Agreements evaluation, or tracking your launch performance.
What makes our data unique
Intelacy is the commercial intelligence arm of APB, providing direct access to pharmacy data at an unmatched scale:
- IFSTAT, 100% coverage at product level
- BelPharData, 85% coverage at patient level
From data to strategic insight
For our partners, the implication is clear: the better your RWD, the stronger your position.
From regulatory submissions to patient journeys, treatment switches and comedication patterns: our data turns pharmacy reality into actionable intelligence.
Curious what our data can reveal for your organization? Let's connect.